The cross-referencing with the PheWAS catalogue revealed that CNTNAP5 polymorphisms are not only associated with glaucoma but also with several other neurodevelopmental and neurological disorders, such as schizophrenia, bipolar disorder, epilepsy, and Alzheimer’s disease [29–32]. Here, CNTNAP5 is linked to early-onset autosomal dominant Alzheimer disease.